睡眠呼吸中止症植入物市场机会、成长驱动因素、产业趋势分析与预测 2024 - 2032 年

2023 年全球睡眠呼吸中止症植入物市场价值为 4.612 亿美元，预计 2024-2032 年复合年增长率为 14.8%。该市场的扩张主要是由于阻塞性睡眠呼吸中止症的上升、CPAP 治疗依从性的挑战以及对睡眠呼吸中止症的认识的提高而推动的。全球阻塞性睡眠呼吸中止症 (OSA) 病例激增是睡眠呼吸中止症植入物市场成长的关键催化剂。美国国立卫生研究院 (NIH) 的数据表明，全球约有 9.36 亿 30-69 岁的成年人受到 OSA 的影响。鑑于 OSA 的广泛影响，对有效治疗解决方案的需求不断增加。

这项全球挑战不仅扩大了对治疗的需求，也凸显了睡眠呼吸中止症植入物等创新疗法，这些疗法有望实现长期管理。整个睡眠呼吸中止症植入物产业根据产品、适应症、最终用途和地区进行分类。睡眠呼吸中止症植入物市场依产品类型分类，腭植入物：舌下神经刺激装置、横膈神经刺激器和接骨螺丝系统。 2023年，舌下神经刺激装置占88.8%的主导市占率。

舌下神经刺激装置在临床试验和现实场景中都显示出令人印象深刻的功效。这使得它们成为中度至重度 OSA 患者的首选，尤其是那些无法耐受持续性呼吸道正压 (CPAP) 治疗的患者。这种有效性巩固了他们的市场领先地位。根据适应症，睡眠呼吸中止症植入物市场分为中枢性睡眠呼吸中止症和阻塞性睡眠呼吸中止症类别。

阻塞性睡眠呼吸中止症细分市场处于领先地位，2023 年估值为4.32 亿美元。低。睡眠呼吸中止症植入物提供了更舒适、更有效的长期替代方案，推动了其在 OSA 领域的应用。 2023 年，北美睡眠呼吸中止症植入物市场估值为 3.583 亿美元，预测分析期间复合年增长率为 14.3%。北美是全球睡眠呼吸中止症植入物市场的领导者。

造成这种主导地位的因素包括睡眠呼吸中止症的高盛行率、健全的医疗基础设施以及对该疾病及其治疗方法的日益认识。此外，该地区在采用尖端医疗技术（包括睡眠呼吸中止症植入物）方面的积极立场得到了主要市场参与者的存在、积极的研发努力以及支持性报销政策的支持。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 阻塞性睡眠呼吸中止症的盛行率不断增加
    • 对 CPAP 的依从性和依从性较低
    • 技术进步
    • 对睡眠呼吸中止症的认识不断提高
  • 产业陷阱与挑战
    • 睡眠呼吸中止症植入物成本高昂
    • 与睡眠呼吸中止症植入物相关的併发症
• 成长潜力分析
• 监管环境
• 报销版图
• 技术景观
• 产品管道分析
• 2023 年定价分析
• 患者旅程地图
• 差距分析
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

• 主要趋势
• 舌下神经刺激装置
• 腭植入物
• 接骨螺丝系统
• 膈神经刺激器

第 6 章：市场估计与预测：按指标划分，2021 - 2032 年

• 主要趋势
• 中枢性睡眠呼吸中止症
• 阻塞性睡眠呼吸中止症

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 医院
• 门诊手术中心
• 其他最终用户

第 8 章：市场估计与预测：按地区划分，2021 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 瑞士
  • 欧洲其他地区
• 世界其他地区

第 9 章：公司简介

• Asahi Kasei Corporation
• Inspire Medical System
• Medtronic plc
• Nyxoah SA
• Siesta Medical, Inc.

The Global Sleep Apnea Implants Market was valued at USD 461.2 million in 2023 and is projected to grow at a CAGR of 14.8% from 2024-2032. The market's expansion is primarily driven by the rising prevalence of obstructive sleep apnea, challenges with compliance to CPAP treatments, and heightened awareness about sleep apnea. The global surge in obstructive sleep apnea (OSA) cases is a key catalyst for the growth of the sleep apnea implant market. Data from the National Institutes of Health (NIH) indicates that around 936 million adults aged 30-69 are globally affected by OSA. Given OSA's widespread impact, there's a mounting demand for effective treatment solutions.

This global challenge is not only amplifying the demand for treatments but also spotlighting innovative therapies like sleep apnea implants, which offer a promise of long-term management. The overall sleep apnea implants industry is classified based on product, indication, end-use, and region. The market for sleep apnea implants is categorized by product types, palatal implants: hypoglossal neurostimulation devices, phrenic nerve stimulators, and bone screw systems. In 2023, hypoglossal neurostimulation devices commanded a dominant market share of 88.8%.

Hypoglossal neurostimulation devices have shown impressive efficacy in both clinical trials and real-world scenarios. This has made them the go-to choice for patients with moderate to severe OSA, especially those who can't tolerate continuous positive airway pressure (CPAP) therapy. Such effectiveness has solidified their leading market position. On the basis of indication, the sleep apnea implants market is divided into central sleep apnea and obstructive sleep apnea categories.

The obstructive sleep apnea segment led the market, boasting a valuation of USD 432 million in 2023. While continuous positive airway pressure (CPAP) therapy is the gold standard for treating OSA, many patients find it uncomfortable, resulting in low compliance. Sleep apnea implants present a more comfortable and effective long-term alternative, driving their uptake in the OSA segment. In 2023, the North American sleep apnea implants market was valued at USD 358.3 million, with projections indicating a CAGR of 14.3% during the analysis period. North America stands as the leader in the global sleep apnea implants market.

Factors contributing to this dominance include a high prevalence of sleep apnea, a robust healthcare infrastructure, and an increasing awareness of the condition and its treatments. Moreover, the region's proactive stance in adopting cutting-edge medical technologies, including sleep apnea implants, is bolstered by the presence of major market players, vigorous research and development endeavors, and supportive reimbursement policies.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of obstructive sleep apnea
    • 3.2.1.2 Low compliance & adherence towards CPAP
    • 3.2.1.3 Technological advancements
    • 3.2.1.4 Rising awareness regarding sleep apnea
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High costs of sleep apnea implants
    • 3.2.2.2 Complications associated with sleep apnea implants
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Reimbursement landscape
• 3.6 Technological landscape
• 3.7 Product pipeline analysis
• 3.8 Pricing analysis, 2023
• 3.9 Patient journey map
• 3.10 Gap analysis
• 3.11 Porter's analysis
• 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn & Units)

• 5.1 Key trends
• 5.2 Hypoglossal neurostimulation devices
• 5.3 Palatal implants
• 5.4 Bone screw systems
• 5.5 Phrenic nerve stimulators

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Central sleep apnea
• 6.3 Obstructive sleep apnea

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn & Units)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Switzerland
  • 8.3.8 Rest of Europe
• 8.4 Rest of World

Chapter 9 Company Profiles

• 9.1 Asahi Kasei Corporation
• 9.2 Inspire Medical System
• 9.3 Medtronic plc
• 9.4 Nyxoah SA
• 9.5 Siesta Medical, Inc.